Formonix Bio-Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.60 M
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Formonix Bio-Pharma
Formonix Bio-Pharma Private Limited (FBPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 April 2021 (Three years and nine months 15 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.60 M, as per Ministry of Corporate Affairs (MCA) records.
Jaideep Tak and Tushar Modak serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24299PN2021PTC200377
- Company No.
200377
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2021
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Formonix Bio-Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaideep Tak  | Director | 16-Apr-2021 | Current |
| Tushar Modak | Director | 16-Apr-2021 | Current |
Financial Performance of Formonix Bio-Pharma.
Formonix Bio-Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Formonix Bio-Pharma?
Unlock access to Formonix Bio-Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Poonawalla Credit Private LimitedJaideep Tak is a mutual person
Magic-Square Hospitality Services LlpJaideep Tak is a mutual person
- Sez Biotech Services Private Limited
Jaideep Tak is a mutual person
- Villoo Poonawalla Racing & Breeding Private Limited
Jaideep Tak is a mutual person
- Vastutech Properties Llp
Tushar Modak is a mutual person
- Curohealth Bio-Pharma Llp
Tushar Modak is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Formonix Bio-Pharma?
Formonix Bio-Pharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Formonix Bio-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Formonix Bio-Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.